Endocura Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Endocura General Information

Description

Developer of local administration of vascular toxic drugs designed to overcome cancer. The company develops vascular blockers, which inhibit tumor blood vessels, enabling the healthcare industry to treat cancer and reduce costs incurred during treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Room 404, 4th floor, 8 Gyeonggyojang-gil
  • Jongno-gu
  • Seoul
  • South Korea
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 404, 4th floor, 8 Gyeonggyojang-gil
  • Jongno-gu
  • Seoul
  • South Korea

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 05-Apr-2024 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Endocura’s complete valuation and funding history, request access »

Endocura Executive Team (1)

Name Title Board Seat
Park Jeongho Chief Executive Officer
To view Endocura’s complete executive team members history, request access »

Endocura Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tap Angel Partners Venture Capital Minority
IBK Changgong Accelerator/Incubator
To view Endocura’s complete investors history, request access »

Ready to get started?

Request a free trial

Endocura FAQs

  • When was Endocura founded?

    Endocura was founded in 2023.

  • Who is the CEO of Endocura?

    Park Jeongho is the CEO of Endocura.

  • Where is Endocura headquartered?

    Endocura is headquartered in Seoul, South Korea.

  • What industry is Endocura in?

    Endocura’s primary industry is Drug Discovery.

  • Is Endocura a private or public company?

    Endocura is a Private company.

  • What is Endocura’s current revenue?

    The current revenue for Endocura is .

  • Who are Endocura’s investors?

    Tap Angel Partners and IBK Changgong have invested in Endocura.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »